Envoy Medical Warrant
COCHW
56 hedge funds and large institutions have $2.77M invested in Envoy Medical Warrant in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
6% more funds holding
Funds holding: 53 → 56 (+3)
30% less capital invested
Capital invested by funds: $3.94M → $2.77M (-$1.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
+$36.5K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$35.5K |
| 3 |
RA
Ramius Advisors
New York
|
+$34.1K |
| 4 |
CS
Clear Street
New York
|
+$27.8K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$21.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$54.3K |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
-$17K |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$13K |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$12K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3K |
COCHW Hedge Fund Activity: Q2 2022 in Review
56 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q2 2022, worth a combined $2.77M — down 30% from $3.94M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new COCHW positions and 7 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Parallax Volatility Advisers, adding an estimated $36.5K. The largest seller was Man Group, exiting entirely with an estimated $54.3K sold.
- 56 institutional investors held Envoy Medical Warrant (COCHW) as of Q2 2022, up from 53 in Q1 2022.
- Funds reported $2.77M of Envoy Medical Warrant stock for Q2 2022, down 30% quarter-over-quarter.
- 10 funds opened new Envoy Medical Warrant positions in Q2 2022 and 7 closed out, a net change of +3 holders.
- The largest Envoy Medical Warrant buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $36.5K added.
- The largest Envoy Medical Warrant seller in Q2 2022 was Man Group, an estimated $54.3K sold.
Based on aggregated 13F filings for Q2 2022.